International Journal of Infection

Published by: Kowsar

Anti-Toxoplasma IgM and IgG Seropositivity Among Individuals Referred to a Clinical Laboratory of Isfahan, Central Iran

Rasool Jafari 1 , * , Shadab Sadeghpour 2 , Forough Sharifi 3 , Hossein Yousofi Darani 1 , Bahram Bagherpour 4 , Pegah Soleimani Salar 3 , Seyedeh Maryam Sharafi 5 , Fereshteh Mohammadi 1 , Nasim Adibpour 6 and Davod Jafari 7
Authors Information
1 Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 School of Medicine, Najafabad Branch, Islamic Azad University, Isfahan, IR Iran
3 Dr. Sharifi Clinical Laboratory, Isfahan, IR Iran
4 Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
5 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
6 Department of Food Science and Technology, College of Agriculture, Isfahan University of Technology, Isfahan, IR Iran
7 Department of Agricultural Biotechnology, Imam Khumaini International University, Qazvin, IR Iran
Article information
  • International Journal of Infection: April 2017, 4 (2); e39522
  • Published Online: August 3, 2016
  • Article Type: Research Article
  • Received: May 27, 2016
  • Revised: June 19, 2016
  • Accepted: June 19, 2016
  • DOI: 10.5812/iji.39522

To Cite: Jafari R, Sadeghpour S, Sharifi F, Yousofi Darani H, Bagherpour B, et al. Anti-Toxoplasma IgM and IgG Seropositivity Among Individuals Referred to a Clinical Laboratory of Isfahan, Central Iran, Int J Infect. 2017 ; 4(2):e39522. doi: 10.5812/iji.39522.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Torrey EF, Yolken RH. Toxoplasma oocysts as a public health problem. Trends Parasitol. 2013; 29(8): 380-4[DOI][PubMed]
  • 2. Dubey JP, Tiao N, Gebreyes WA, Jones JL. A review of toxoplasmosis in humans and animals in Ethiopia. Epidemiol Infect. 2012; 140(11): 1935-8[DOI][PubMed]
  • 3. Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J Trop Med Public Health. 2009; 40(6): 1158-78[PubMed]
  • 4. Oz HS. Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon. Front Microbiol. 2014; 5: 385[DOI][PubMed]
  • 5. Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop. 2014; 137: 185-94[DOI][PubMed]
  • 6. Cook TB, Brenner LA, Cloninger CR, Langenberg P, Igbide A, Giegling I, et al. "Latent" infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J Psychiatr Res. 2015; 60: 87-94[DOI][PubMed]
  • 7. Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol. 2013; 216: 127-33[DOI][PubMed]
  • 8. Hill DE, Chirukandoth S, Dubey JP. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev. 2005; 6(1): 41-61[PubMed]
  • 9. Hoghooghi-Rad N, Afraa M. Prevalence of toxoplasmosis in humans and domestic animals in Ahwaz, capital of Khoozestan Province, south-west Iran. J Trop Med Hyg. 1993; 96(3): 163-8[PubMed]
  • 10. Mahmoudvand H, Saedi Dezaki E, Soleimani S, Baneshi MR, Kheirandish F, Ezatpour B, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran. Parasite Immunol. 2015; 37(7): 362-7[DOI][PubMed]
  • 11. Sharbatkhori M, Dadi Moghaddam Y, Pagheh AS, Mohammadi R, Hedayat Mofidi H, Shojaee S. Seroprevalence of Toxoplasma gondii Infections in Pregnant Women in Gorgan City, Golestan Province, Northern Iran-2012. Iran J Parasitol. 2014; 9(2): 181-7[PubMed]
  • 12. Ezatpour B, Zibaie M, Rahmati H, Pournia Y, Azami M, Ebrahimzadeh F, et al. Seroprevalence of toxoplasmosis in mentally retarded patients in Iranian rehabilitation centers. J Parasit Dis. 2015; 39(1): 13-7[DOI][PubMed]
  • 13. Ghasemloo H, Ghomashlooyan M, Hooshyar H. Seroprevalence of Toxoplasma gondii infection among pregnant women admitted at Shahid Akbar Abadi hospital, Tehran, Iran, 2010-2013. J Med Microbiol Infect Dis. 2014; 2(1): 16-8
  • 14. Rasouli S, Sadaghian M, Jafari R. Prevalence of human toxoplasmosis and related risk factors using Electrochemiluminescence (ECLIA) method in West Azarbaijan Province, Iran, 2010. Int J Biosci. 2014; 4(8): 124-30
  • 15. Fallah M, Rabiee S, Matini M, Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East Mediterr Health J. 2008; 14(1): 163-71[PubMed]
  • 16. Tasawar Z, Aziz F, Lashari MH, Shafi S, Ahmad M, Lal V, et al. Seroprevalence of Human toxoplasmosis in southern Punjab, Pakistan. Pak J Life Soc Sci. 2012; 10: 48-52
  • 17. Abu-Madi MA, Al-Molawi N, Behnke JM. Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Parasit Vectors. 2008; 1(1): 39[DOI][PubMed]
  • 18. Xiao Y, Yin J, Jiang N, Xiang M, Hao L, Lu H, et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis. 2010; 10: 4[DOI][PubMed]
  • 19. Meisheri YV, Mehta S, Patel U. A prospective study of seroprevalence of Toxoplasmosis in general population, and in HIV/AIDS patients in Bombay, India. J Postgrad Med. 1997; 43(4): 93-7[PubMed]
  • 20. Galvan-Ramirez Mde L, Troyo R, Roman S, Calvillo-Sanchez C, Bernal-Redondo R. A systematic review and meta-analysis of Toxoplasma gondii infection among the Mexican population. Parasit Vectors. 2012; 5: 271[DOI][PubMed]
  • 21. Mohraz M, Mehrkhani F, Jam S, SeyedAlinaghi S, Sabzvari D, Fattahi F, et al. Seroprevalence of toxoplasmosis in HIV(+)/AIDS patients in Iran. Acta Med Iran. 2011; 49(4): 213-8[PubMed]
  • 22. Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A. Seroepidemiology of Toxoplasma gondii infection in Isfahan province, central Iran: A population based study. J Res Med Sci. 2011; 16(4): 496-501[PubMed]
  • 23. Mostafavi N, Ataei B, Nokhodian Z, Monfared LJ, Yaran M, Ataie M, et al. Toxoplasma gondii infection in women of childbearing age of Isfahan, Iran: A population-based study. Adv Biomed Res. 2012; 1: 60[DOI][PubMed]
  • 24. Mohammadi A, Shojaee S, Salimi M, Zareei M, Mohebali M, Keshavarz H. Seroepidemiological Study of Toxoplasmosis in Women Referred to Arak Marriage Consulting Center during 2012-2013. Iran J Public Health. 2015; 44(5): 654-8[PubMed]
  • 25. Haywood B, Patel M, Hurday S, Copping R, Webster D, Irish D, et al. Comparison of automated chemiluminescence immunoassays with capture enzyme immunoassays for the detection of measles and mumps IgM antibodies in serum. J Virol Methods. 2014; 196: 15-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments